Stephanie Diaz | Manager-Investor Relations |
Brian Lian | President and Chief Executive Officer |
Greg Zante | Chief Financial Officer |
Jay Olson | Oppenheimer |
Steven Seedhouse | Raymond James |
Joe Pantginis | H.C. Wainwright |
Scott Henry | ROTH Capital |
Yale Jen | Laidlaw & Company |
Andy Hsieh | William Blair |
Justin Zelin | BTIG |
Good day and welcome to the Viking Therapeutics 2022 First Quarter Financial Results Conference Call. [Operator instructions].
As a reminder, this conference call is being recorded today, April 27, 2022. I would now like to turn the conference over to Viking’s Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.